Biomed Central Ltd

SHERPA: Unknown

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Brogi
    Brogi
  4. Chandarlapaty
    Chandarlapaty
  5. Morrow
    Morrow
  6. Solomon
    Solomon
  7. D'Andrea-Carlino
    D'Andrea-Carlino
  8. Gajria
    Gajria
  9. Haque
    Haque
  10. Janjigian
    Janjigian

Groups

  1. Breast Medicine Service (9)
  2. Department of Medicine (9)
  3. Solid Tumor Oncology Division (9)
  4. Survivorship Research (9)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  6. GSK Faculty (5)
  7. Biostatistics Service (4)
  8. Epidemiology and Biostatistics (4)
  9. Radiology, Department of (3)
  10. Center for Pancreatic Cancer Research (2)
Search Within
  1. "Clifford Hudis"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (3)
Groups
  1. Breast Medicine Service (9)
  2. Department of Medicine (9)
  3. Solid Tumor Oncology Division (9)
  4. Survivorship Research (9)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  6. GSK Faculty (5)

More Groups

People
  1. Clifford Hudis (9)
  2. Larry Norton (4)
  3. Sujata Patil (3)
  4. David Page (2)
  5. Edi Brogi (2)
  6. Heather Mcarthur (2)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2015 (1)
  4. 2014 (1)
  5. 2013 (2)
  6. 2011 (1)

More Years

Publications
  1. Breast Cancer Research (5)
  2. Journal for ImmunoTherapy of Cancer (2)
  3. BMC Cancer (1)
  4. Trials (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Breast carcinoma with 21-gene recurrence score lower than 18: Rate of locoregional recurrence in a large series with clinical follow-up
    Journal Article

    Turashvili, G.; Brogi, E.; Morrow, M.; Dickler, M.; Norton, L.; Hudis, C.; Wen, H. Y.
    BMC Cancer (2018)

    Fulltext@MSK | Save
  • A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Wang, R.; Teplinsky, E.; Chandarlapaty, S.; Solit, D.; Cadoo, K.; Speyer, J.; D'Andrea, G.; Adams, S.; Patil, S.; more...
    Breast Cancer Research (2017)

    Fulltext@MSK | Save
  • Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
    Meeting Abstract

    Page, D. B.; Diab, A.; Yuan, J.; Dong, Z.; Soloman, S. B.; Patil, S.; Hudis, C. A.; Wolchok, J. D.; Norton, L.; McArthur, H. L.
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save
  • Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
    Meeting Abstract

    Page, D. B.; McArthur, H.; Dong, Z.; Wong, P.; Emerson, R.; Mu, Z.; Zhao, C.; Comstock, C.; Morris, E.; Comen, E.; more...
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
    Journal Article

    Hudis, C.; Swanton, C.; Janjigian, Y. Y.; Lee, R.; Sutherland, S.; Lehman, R.; Chandarlapaty, S.; Hamilton, N.; Gajria, D.; Knowles, J.; more...
    Breast Cancer Research (2013)

    Fulltext@MSK | Save
  • A phase 3 trial comparing capecitabine in combination with SorafenIb or placebo for treatment of locally advanced or metastatIc HER2-negative breast Cancer (the RESILIENCE study): Study protocol for a randomized controlled trial
    Journal Article

    Baselga, J.; Costa, F.; Gomez, H.; Hudis, C. A.; Rapoport, B.; Roche, H.; Schwartzberg, L. S.; Petrenciuc, O.; Shan, M.; Gradishar, W. J.
    Trials (2013)

    Fulltext@MSK | Save
  • Design of RESILIENCE: A phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer
    Meeting Abstract

    Baselga, J.; Costa, F.; Gomez, H.; Hudis, C.; Rapoport, B.; Roche, H.; Schwartzberg, L. S.; Petrenciuc, O.; Shan, M.; Gradishar, W. J.
    Breast Cancer Research (2011)

    Fulltext@MSK | Save
  • Clinical utility and future of genetic profiles for breast cancer
    Journal Article

    Hudis, C.
    Breast Cancer Research (2009)

    Fulltext@MSK | Save
  • A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
    Journal Article

    Robson, M. E.; Chappuis, P. O.; Satagopan, J.; Wong, N.; Boyd, J.; Goffin, J. R.; Hudis, C.; Roberge, D.; Norton, L.; Begin, L. R.; more...
    Breast Cancer Research (2003)

    Fulltext@MSK | Save